Amgen | 227.7300 / +2.62% |
News
- SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Five Prime Therapeutics, Inc. Buyout
03/04/2021 / 19:43 - GlobeNewswire - FIVE PRIME ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of FPRX and Encourages Investors to Contact the Firm
03/04/2021 / 18:02 - GlobeNewswire - Entera Bio To Present At The H.C. Wainwright Global Life Sciences Conference
03/04/2021 / 14:30 - GlobeNewswire - Orphazyme appoints Christophe Bourdon as Chief Executive Officer
03/01/2021 / 07:00 - GlobeNewswire - Cytokinetics Reports Fourth Quarter 2020 Financial Results
02/25/2021 / 22:00 - GlobeNewswire - Entera Bio Announces Publication of Phase 2 Hypoparathyroidism Study in the Journal of Bone and Mineral Research
02/25/2021 / 14:30 - GlobeNewswire - CytomX Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
02/24/2021 / 22:15 - GlobeNewswire - CytomX Therapeutics to Present at Upcoming March Virtual Investor Conferences
02/22/2021 / 14:00 - GlobeNewswire - CytomX Therapeutics Announces New Employment Inducement Grant
02/19/2021 / 14:00 - GlobeNewswire - Adverum Appoints Christopher J. DeRespino as Chief Business Officer
02/18/2021 / 22:00 - GlobeNewswire - Monopar Expands Clinical Team with Appointment of Laura Kelly as Director of Clinical Operations
02/18/2021 / 13:00 - GlobeNewswire - CytomX Therapeutics to Announce Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021
02/17/2021 / 14:00 - GlobeNewswire - Royalty Pharma Reports Q4 2020 and Full-Year Results
02/17/2021 / 13:00 - GlobeNewswire - Affinia Therapeutics Announces Addition of Gene Therapy Scientific and Medical Experts to Leadership Team to Advance Novel Gene Therapy Platform and Programs to the Clinic
02/17/2021 / 12:30 - GlobeNewswire - Resilinc Launches Predictive Purchase Order (PO) On-Time Delivery Solution
02/16/2021 / 16:00 - GlobeNewswire